Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga (dapagliflozin) as an option to treat chronic ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

Japanese drugmaker Astellas Pharma (TYO: 4503) today announced an exclusive license agreement with China’s Evopoint ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...